Understanding how insulin works in the liver
Novel regulation of insulin action in the liver
This study is looking at how insulin helps control sugar and fat in the liver, especially focusing on a specific enzyme called Lpcat3, to understand why some people develop insulin resistance, which is important for managing type 2 diabetes, and it hopes to find new ways to improve insulin function and blood sugar control for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-11023100 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which insulin regulates glucose and lipid metabolism in the liver, particularly focusing on a specific enzyme called Lpcat3. By studying how changes in lipid composition affect insulin signaling, the research aims to uncover the reasons behind insulin resistance, a key factor in type 2 diabetes. Patients may benefit from insights that could lead to new treatments or strategies to improve insulin action and manage blood sugar levels more effectively.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type 2 diabetes or those experiencing insulin resistance.
Not a fit: Patients without insulin resistance or type 2 diabetes may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for managing insulin resistance and type 2 diabetes.
How similar studies have performed: Previous research has shown promising results in understanding insulin signaling and its implications for diabetes treatment, suggesting that this approach could yield valuable insights.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Wang, Bo — University of Illinois at Urbana-Champaign
- Study coordinator: Wang, Bo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.